Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data

Authors

Yohei Mikami (ORCID: https://orcid.org/0000-0001-5104-4415)
Shinichiro Shinzaki (ORCID: https://orcid.org/0000-0002-7051-618X)
Yutaka Endo (ORCID: https://orcid.org/0000-0001-7187-0124)
Toshimitsu Fujii (ORCID: https://orcid.org/0000-0003-3048-7270)
Satoshi Motoya (ORCID: https://orcid.org/0000-0002-4194-8493)
Katsuyoshi Matsuoka (ORCID: https://orcid.org/0000-0002-2950-7660)
Shoko Arai (ORCID: https://orcid.org/0000-0003-4609-1609)
Takayuki Yamamoto (ORCID: https://orcid.org/0000-0001-8216-0750)
Hirotoshi Yuasa (ORCID: https://orcid.org/0009-0007-2067-7392)
Masato Hoshi (ORCID: https://orcid.org/0000-0003-2874-1807)
Minoru Matsuura
Junichi Oshima
Keiko Sato (ORCID: https://orcid.org/0009-0009-1270-6725)
Tadakazu Hisamatsu

Institutions

Toho University (JP)
Kyorin University (JP)
Keio University (JP)
Japan Pediatric Society (JP)
Yokkaichi Social Insurance Hospital (JP)
Sapporo Kosei General Hospital (JP)
Toho University Medical Center Sakura Hospital (JP)
Pfizer (Japan) (JP)
Institute of Science Tokyo (JP)
Hyogo University (JP)

Publication Details

Journal: Journal of Gastroenterology
Published: 2025-04-21
DOI: https://doi.org/10.1007/s00535-025-02249-5
Primary Topic: Inflammatory Bowel Disease
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Pfizer

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data

Yohei Mikami, Shinichiro Shinzaki, Yutaka Endo, Toshimitsu Fujii et al.

Apr 21, 2025

1 links

Journal of Gastroenterology

Inflammatory Bowel Disease

article

Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a final report of safety and effectiveness data

Yohei Mikami, Shinichiro Shinzaki, Yutaka Endo, Toshimitsu Fujii, Satoshi Motoya, Katsuyoshi Matsuoka, Shoko Arai, Takayuki Yamamoto, Hirotoshi Yuasa, Masato Hoshi, Minoru Matsuura, Junichi Oshima, Keiko Sato, Tadakazu Hisamatsu

April 21, 2025article en

Abstract

No abstract available for this paper.

Journal of GastroenterologyVol. 60(8)

Toho University (JP), Kyorin University (JP), Keio University (JP), Japan Pediatric Society (JP), Yokkaichi Social Insurance Hospital (JP), Sapporo Kosei General Hospital (JP), Toho University Medical Center Sakura Hospital (JP), Pfizer (Japan) (JP), Institute of Science Tokyo (JP), Hyogo University (JP)

Pfizer

Good health and well-being

Openalex Percentile: Top 90%

Inflammatory Bowel Disease

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.